| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.057 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.052 | 0.8 |